Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

FRTX holding history

Fresh Tracks Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FRTX overviewAll 13F holders of FRTXFull Q2 2026 holdings

Shares (Q2 2022)
0
Sold out in Q2 2022
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q2 2021
Holdings of FRTX by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20220$00.0%−137,423−100.0%Sold outHolders
Q1 2022137,423$37.0K<0.1%−31,164−18.5%ReducedHolders
Q4 2021168,587$39.0K<0.1%+89,038+111.9%AddedHolders
Q3 202179,549$57.0K<0.1%−811−1.0%ReducedHolders
Q2 202180,360$76.0K<0.1%+80,360NewHolders